Adam Karns

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension

Adam Karns, Jacqueline M. Bral, Daniel Hartman et al. · Journal of Clinical Hypertension · 2012 · 89 citations · Full text

Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study

Patrick M. Moriarty, Eli M. Roth, Adam Karns et al. · Journal of clinical lipidology · 2014 · 60 citations

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +10

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension

Akshay S. Desai, Adam Karns, Jolita Badarienė et al. · JAMA · 2025 · 16 citations · Full text